10 results on '"D. Chatfield"'
Search Results
2. National predictors of influenza vaccine uptake in pregnancy: the FluMum prospective cohort study, Australia, 2012–2015
- Author
-
Lisa McHugh, Kerry‐Ann F. O'Grady, Terry Nolan, Peter C. Richmond, Nicholas Wood, Helen S. Marshall, Stephen B. Lambert, Mark D. Chatfield, Kirsten P. Perrett, Paula Binks, Michael J. Binks, and Ross M. Andrews
- Subjects
influenza ,vaccination ,pregnancy ,predictors ,Public aspects of medicine ,RA1-1270 - Abstract
Abstract Objective: Ascertain predictors of inactivated influenza vaccine (IIV) uptake in pregnancy in mother–infant pairs from six Australian sites over four consecutive influenza seasons (2012–2015). Methods: Prospective observational cohort study calculating proportions of unvaccinated and vaccinated pregnancies. Multivariable logistic regression calculating adjusted odds ratios (aOR) and 95% confidence intervals (95%CI) to determine demographic, pregnancy and birth characteristics as predictors of IIV uptake in pregnancy. Results: Uptake of IIV was 36% (n=3,651/9,878) with only 3–4% during the first trimester. Validation of IIV receipt was obtained for 77% of vaccinated participants. Predictors of IIV uptake in pregnancy were: healthcare provider recommendation to have IIV during pregnancy (aOR 7.04 [95%CI 5.83‐8.50]): GP (aOR 4.12 [95%CI 3.43‐4.98]), obstetrician (aOR 4.41 [95%CI 3.45‐5.64]), midwife (aOR 1.88 [95%CI 1.51‐2.36]); previous IIV within 12 months of their current pregnancy (aOR 2.87 [95%CI 2.36‐3.50]); and pertussis vaccination during the current pregnancy (aOR 4.88 [95%CI 4.08‐5.83]). Conclusions and implications for public health: Healthcare provider discussions with pregnant women about the risks associated with influenza infection during pregnancy and early infancy and evidence about the safety and effectiveness of IIV are required. Recommending and offering IIV in pregnancy needs to be included in these discussions to improve uptake.
- Published
- 2021
- Full Text
- View/download PDF
3. Associations between lung function and future cardiovascular morbidity and overall mortality in a predominantly First Nations population: a cohort study.
- Author
-
Andrew J Collaro, Anne B Chang, Julie M Marchant, Mark D Chatfield, Annette Dent, Tamara Blake, Patsi Mawn, Kwun Fong, and Margaret S McElrea
- Subjects
Respiratory Medicine ,First Nations ,Cardiovascular Disease ,lung function ,spirometry ,Outcomes ,Public aspects of medicine ,RA1-1270 - Abstract
Summary: Background: Spirometric lung function impairment is an independent predictor of respiratory and cardiovascular disease, and mortality across a broad range of socioeconomic backgrounds and environmental settings. No contemporary studies have explored these relationships in a predominantly regional/remote First Nations population, whose health outcomes are worse than for non-First Nations populations, and First Nations people living in urban centres. Methods: This was a retrospective cohort study of 1,734 adults (1,113 First Nations) referred to specialist respiratory outreach clinics in the state of Queensland, Australia from February 2012 to March 2020. Regression modelling was used to test associations between lung function and mortality and cardiovascular disease. Findings: At the time of analysis (August 2020), 189 patients had died: 88 (47%) from respiratory causes and 38 (20%) from cardiovascular causes. When compared to patients with forced expiratory volume in one second (FEV1) and forced vital capacity (FVC) Z-scores of >0 to -1, patients with Z-scores
- Published
- 2021
- Full Text
- View/download PDF
4. Interchangeability, immunogenicity and safety of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (Synflorix) and 13-valent-PCV (Prevenar13) schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trial
- Author
-
Amanda Jane Leach, Edward Kim Mulholland, Mathuram Santosham, Paul John Torzillo, Peter McIntyre, Heidi Smith-Vaughan, Nicole Wilson, Beth Arrowsmith, Jemima Beissbarth, Mark D. Chatfield, Victor M. Oguoma, Paul Licciardi, Sue Skull, Ross Andrews, Jonathan Carapetis, Joseph McDonnell, Vicki Krause, and Peter Stanley Morris
- Subjects
Aboriginal and Torres Strait Islander ,Mixed schedule primary course vaccination ,Pneumococcal conjugate vaccines ,Randomised controlled trial ,Non-typeable Haemophilus influenzae protein D ,Immunologic diseases. Allergy ,RC581-607 - Abstract
Background: Aboriginal children living in remote communities are at high risk of early and persistent otitis media. Streptococcus pneumoniae and non-typeable Haemophilus influenzae (NTHi) are primary pathogens. Vaccines with potential to prevent early OM have not been evaluated in this population. We compared immunogenicity (ELISA and opsonophagocytic activity) of a combination of Synflorix™ (PHiD-CV10, 10 serotypes and protein D of NTHi) and Prevenar13™ (PCV13, 10 serotypes plus 3, 6A, and 19A), with recommended schedules. Methods: This open-label superiority trial randomised (1:1:1) Aboriginal infants at 28 to 38 days of age, to PCV13 (P) at 2–4-6 months (_PPP), PHiD-CV10 (S) at 2–4-6 months (_SSS), or PHiD-CV10 at 1–2–4 plus PCV13 at −6 months (SSSP). Primary outcomes (blinded) were immunogenicity against PCV13-only serotypes 3, 6A, 19A, and PHiD-CV10-only protein D at 7 months. Secondary outcomes include immunogenicity against all serotypes at 2, 4 and 7 months. Findings: Between 2011 and 2017, 425 infants were allocated to _PPP(143), _SSS(141) or SSSP(141). An intention to treat approach including all available data was used. The SSSP group had superior immunogenicity against serotypes 3, 6A, and 19A compared to _SSS (OPA GMT ratios 8.1 to 59.5, p
- Published
- 2021
- Full Text
- View/download PDF
5. Reduced red blood cell deformability in Plasmodium knowlesi malaria
- Author
-
Bridget E. Barber, Bruce Russell, Matthew J. Grigg, Rou Zhang, Timothy William, Amirah Amir, Yee Ling Lau, Mark D. Chatfield, Arjen M. Dondorp, Nicholas M. Anstey, and Tsin W. Yeo
- Subjects
Specialties of internal medicine ,RC581-951 - Abstract
Abstract: The simian parasite Plasmodium knowlesi can cause severe and fatal human malaria. However, little is known about the pathogenesis of this disease. In falciparum malaria, reduced red blood cell deformability (RBC-D) contributes to microvascular obstruction and impaired organ perfusion. In P knowlesi infection, impaired microcirculatory flow has been observed in Macaca mulatta (rhesus macaques), unnatural hosts who develop severe and fatal disease. However, RBC-D has not been measured in human infection or in the natural host M fascicularis (long-tailed macaques). Using ektacytometry, we measured RBC-D in adults with severe and non-severe knowlesi and falciparum malaria and in healthy controls. In addition, we used micropipette aspiration to determine the relative stiffness of infected RBCs (iRBCs) and uninfected RBCs (uRBCs) in P knowlesi–infected humans and M fascicularis. Ektacytometry demonstrated that RBC-D overall was reduced in human knowlesi malaria in proportion to disease severity, and in severe knowlesi malaria, it was comparable to that of severe falciparum malaria. RBC-D correlated inversely with parasitemia and lactate in knowlesi malaria and HRP2 in falciparum malaria, and it correlated with hemoglobin nadir in knowlesi malaria. Micropipette aspiration confirmed that in humans, P knowlesi infection increased stiffness of both iRBCs and uRBCs, with the latter mostly the result of echinocytosis. In contrast, in the natural host M fascicularis, echinocyte formation was not observed, and the RBC-D of uRBCs was unaffected. In unnatural primate hosts of P knowlesi, including humans, reduced deformability of iRBCs and uRBCs may represent a key pathogenic mechanism leading to microvascular accumulation, impaired organ perfusion, and anemia.
- Published
- 2018
- Full Text
- View/download PDF
6. A follow‐up of sunscreen use and sun‐protection practices in Darwin: a cross‐sectional survey
- Author
-
Joyce H.Y. Ma, Mark D. Chatfield, Kirsty Campbell, and Dev Tilakaratne
- Subjects
Public aspects of medicine ,RA1-1270 - Published
- 2019
- Full Text
- View/download PDF
7. Effect of a price discount and consumer education strategy on food and beverage purchases in remote Indigenous Australia: a stepped-wedge randomised controlled trial
- Author
-
Dr Julie Brimblecombe, PhD, Megan Ferguson, MPH, Mark D Chatfield, MSc, Selma C Liberato, PhD, Anthony Gunther, Prof Kylie Ball, PhD, Prof Marj Moodie, DrPH, Edward Miles, Anne Magnus, PGDip, Prof Cliona Ni Mhurchu, PhD, Prof Amanda Jane Leach, PhD, and Prof Ross Bailie, MD
- Subjects
Public aspects of medicine ,RA1-1270 - Abstract
Background: Evidence is mounting that price discounts can be effective in improving diet. This study examined the effectiveness of a 20% price discount on food and drink purchases with and without consumer education in remote Indigenous Australia. Methods: A 20% discount on fruit, vegetables, water, and artificially sweetened soft drinks was applied for 24 weeks in 20 communities in remote Indigenous Australia where the community store was managed by the Arnhem Land Progress Aboriginal Corporation (ALPA) or Outback Stores (OBS) in a stepped-wedge randomised trial. Communities were randomly allocated to a fixed framework of five sets of four stratified by store association; ten stores (two in each set) were randomly assigned to receive consumer education. A store from each of the ALPA and OBS store groups (contained in separate opaque envelopes) was selected, and stores in turn continued to be consecutively allocated to the fixed store set framework, starting with the first store slot in the first store set, until all stores had been allocated. The effect of the discount on the weight of fruit and vegetables purchased (the primary endpoint) was assessed using weekly store sales data and mixed models per protocol. We did sensitivity analyses by repeating the analyses with the outliers included and repeating the analyses for the primary outcome measure removing each store one at a time. This trial was registered with Australian New Zealand Clinical Trials Registry, number ACTRN12613000694718. Findings: Weekly store sales data on all food and drink products sold in 20 stores were collected from July 1, 2012, to Dec 28, 2014. Price discount alone was associated with a 12·7% (95% CI 4·1–22·1) increase in purchases in grams of fruit and vegetables combined (primary outcome), and a 19·8% (6·2–35·1) increase post discount (after vs before); an effect of 12 g and 18 g per capita per day. Sensitivity analyses did not modify the results for the primary outcome measure. Interpretation: A 20% discount can only increase fruit and vegetable purchases to help protect against obesity and diet related disease to a certain extent. Large discounts might have a greater impact than small discounts. Creative merchandising approaches to consumer education could also be considered alongside fiscal interventions to achieve marked improvements in diet. Funding: Australian National Health and Medical Research Council.
- Published
- 2017
- Full Text
- View/download PDF
8. Associations between lung function and future cardiovascular morbidity and overall mortality in a predominantly First Nations population: a cohort study
- Author
-
Julie M. Marchant, Anne B. Chang, Tamara L. Blake, Mark D. Chatfield, Kwun M. Fong, Andrew J. Collaro, Annette Dent, Margaret S. McElrea, and Patsi Mawn
- Subjects
Spirometry ,Vital capacity ,Population ,spirometry ,Disease ,Outcomes ,FEV1/FVC ratio ,Cardiovascular Disease ,Internal Medicine ,medicine ,education ,Socioeconomic status ,Respiratory Medicine ,First Nations ,education.field_of_study ,medicine.diagnostic_test ,business.industry ,Health Policy ,Public Health, Environmental and Occupational Health ,Obstetrics and Gynecology ,Retrospective cohort study ,lung function ,Psychiatry and Mental health ,Infectious Diseases ,Pediatrics, Perinatology and Child Health ,Public aspects of medicine ,RA1-1270 ,Geriatrics and Gerontology ,business ,Demography ,Cohort study ,Research Paper - Abstract
Summary: Background: Spirometric lung function impairment is an independent predictor of respiratory and cardiovascular disease, and mortality across a broad range of socioeconomic backgrounds and environmental settings. No contemporary studies have explored these relationships in a predominantly regional/remote First Nations population, whose health outcomes are worse than for non-First Nations populations, and First Nations people living in urban centres. Methods: This was a retrospective cohort study of 1,734 adults (1,113 First Nations) referred to specialist respiratory outreach clinics in the state of Queensland, Australia from February 2012 to March 2020. Regression modelling was used to test associations between lung function and mortality and cardiovascular disease. Findings: At the time of analysis (August 2020), 189 patients had died: 88 (47%) from respiratory causes and 38 (20%) from cardiovascular causes. When compared to patients with forced expiratory volume in one second (FEV1) and forced vital capacity (FVC) Z-scores of >0 to -1, patients with Z-scores
- Published
- 2021
9. PneuMum: Impact from a randomised controlled trial of maternal 23-valent pneumococcal polysaccharide vaccination on middle ear disease amongst Indigenous infants, Northern Territory, Australia
- Author
-
Paul J. Torzillo, Jonathan R. Carapetis, Kim M. Hare, Sarah A. Moberley, Sandra Nelson, Jane Nelson, Mark D. Chatfield, Peter S. Morris, Mimi L.K. Tang, Anne Balloch, Amanda J. Leach, Ross M. Andrews, E. Kim Mulholland, Michael J. Binks, and C. Wilson
- Subjects
Pediatrics ,Native Hawaiian or Other Pacific Islander ,Ear disease ,Pneumococcal Vaccines ,0302 clinical medicine ,Pregnancy ,Nasopharynx ,Prevalence ,Medicine ,030212 general & internal medicine ,Young adult ,education.field_of_study ,Vaccination ,Pneumococcus ,3. Good health ,Infectious Diseases ,Streptococcus pneumoniae ,Carrier State ,Gestation ,Molecular Medicine ,Female ,Adult ,medicine.medical_specialty ,Adolescent ,Population ,Pneumococcal Infections ,23-valent pneumococcal polysaccharide vaccine ,03 medical and health sciences ,Young Adult ,030225 pediatrics ,Immunology and Microbiology(all) ,Northern Territory ,Humans ,education ,General Veterinary ,General Immunology and Microbiology ,business.industry ,Australia ,Public Health, Environmental and Occupational Health ,Infant ,medicine.disease ,Vaccine efficacy ,veterinary(all) ,Indigenous ,Otitis Media ,Carriage ,business ,Immunity, Maternally-Acquired - Abstract
Background We assessed maternal 23-valent pneumococcal polysaccharide (23vPPV) vaccine efficacy (VE) against middle ear disease and pneumococcal carriage amongst Australian Indigenous infants. Methods In an open label, allocation concealed, outcome-assessor blinded, community stratified, randomised controlled trial, healthy pregnant Indigenous women aged 17–39 years in the Northern Territory of Australia received the 23vPPV (1:1:1) at: 30–36 weeks gestation, birth, or were unvaccinated (ClinicalTrials.gov NCT00714064). Co-primary outcomes were the point prevalences of infant middle ear disease and 23vPPV-type carriage at age 7 months. Results The consent rate was 50% (313/632). Among 227 eligible participants randomised, retention rates were 86% (66/77) controls; 89% (67/75) pregnancy vaccinees; 88% (66/75) birth vaccinees. At infant age 7 months, ear disease prevalence was: 71% (47/66) controls, 63% (42/67) pregnancy vaccinees, 76% (50/66) birth vaccinees; and 23vPPV-type carriage was: 26% (17/66) controls, 18% (12/67) pregnancy vaccinees, 18% (12/66) birth vaccinees. For pregnancy vaccinees, VE was 12% (95% CI −12% to 31%) against infant ear disease and 30% (95% CI −34% to 64%) against 23vPPV-type carriage. In a post-hoc analysis, VE against infant ear disease concurrent with carriage of 23vPPV or related types was 51% (95% CI −2% to 76%). There were no serious adverse effects following receipt of the 23vPPV in pregnancy or at birth. Conclusions In a high risk population, our study was unable to demonstrate efficacy of 23vPPV in pregnancy against the co-primary outcomes of either all-cause infant ear disease or 23vPPV-type nasopharyngeal carriage at age 7 months. Efficacy against ear disease concurrent with carriage of vaccine-related serotypes (a more specific outcome) suggests 23vPPV in pregnancy may complement childhood pneumococcal vaccination programs.
- Published
- 2015
10. Providing coaching and cotinine results to preteens to reduce their secondhand smoke exposure: a randomized trial.
- Author
-
Hovell MF, Wahlgren DR, Liles S, Jones JA, Hughes SC, Matt GE, Ji M, Lessov-Schlaggar CN, Swan GE, Chatfield D, and Ding D
- Subjects
- Adolescent, Child, Environmental Exposure prevention & control, Female, Health Behavior, Humans, Male, Motivation, Cotinine urine, Counseling, Health Education methods, Tobacco Smoke Pollution prevention & control
- Abstract
Background: Secondhand smoke exposure (SHSe) poses health risks to children living with smokers. Most interventions to protect children from SHSe have coached adult smokers. This trial determined whether coaching and cotinine feedback provided to preteens can reduce their SHSe., Methods: Two hundred one predominantly low-income families with a resident smoker and a child aged 8 to 13 years who was exposed to two or more cigarettes per day or had a urine cotinine concentration ≥ 2.0 ng/mL were randomized to control or SHSe reduction coaching groups. During eight in-home sessions over 5 months, coaches presented to the child graphic charts of cotinine assay results as performance feedback and provided differential praise and incentives for cotinine reductions. Generalized estimating equations were used to determine the differential change in SHSe over time by group., Results: For the baseline to posttest period, the coaching group had a greater decrease in both urine cotinine concentration (P = .039) and reported child SHSe in the number of cigarettes exposed per day (child report, P = .003; parent report, P = .078). For posttest to month 12 follow-up, no group or group by time differences were obtained, and both groups returned toward baseline., Conclusions: Coaching preteens can reduce their SHSe, although reductions may not be sustained without ongoing counseling, feedback, and incentives. Unlike interventions that coach adults to reduce child SHSe, programs that increase child avoidance of SHSe have the potential to reduce SHSe in all settings in which the child is exposed, without requiring a change in adult smoking behavior.
- Published
- 2011
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.